Iridia, Inc.
PrivateLast Round
Grant
Mar 29, 2022
Total Funding Raised
$33.15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Iridia, Inc. operates in AI, Data & Cloud Infrastructure and is based in Carlsbad, California. Its latest recorded funding round was a Grant round in March 2022.
Iridia, Inc. is a nanotechnology company that develops DNA-based data storage solutions and molecular identity technology for product authentication, traceability, and supply chain security.
Sector
AI, Data & Cloud Infrastructure
Verticals
Cloud Infrastructure, Biotechnology, Digital Identity
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iridia, Inc. Comparables
Compare Iridia, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Catalog Technologies | 86% | |
| Biomemory | 81% | |
| Helixworks Technologies | 81% |
For institutional investors. Book with your work email.
Iridia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 29, 2022 | ||||
| Series B Extension | Dec 14, 2021 | ||||
| Series B | Mar 16, 2021 | ||||
| Series A | Jun 1, 2018 | ||||
| Seed | Aug 24, 2017 | ||||
Seed | Jun 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iridia, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeSci Venture Partners | Series B |
| Longley Capital | Series B |
| NIH RADx | Grant |
| Tech Coast Angels | Series B, Seed, Series A |
| Pritzker Vlock Family Office | Series B |
| Validex Global Investing | Series B |
| Prime Movers Lab | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 42% MoM.
- Jul 26, 2026
Monthly visitors grew 408% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Iridia, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iridia, Inc.'s valuation, stock price, and market status.
Is Iridia, Inc. a public or private company?
Iridia, Inc. is a private company.
What is the current stock price of Iridia, Inc.?
Iridia, Inc. is a private company, so its shares have no public market price. Caplight tracks Iridia, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iridia, Inc. worth (valuation)?
Valuation information for Iridia, Inc. is not publicly available.
Can I buy Iridia, Inc. stock?
Iridia, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iridia, Inc.'s last funding round?
Iridia, Inc.'s most recent funding round was Grant on March 29, 2022.
Who are the main investors in Iridia, Inc.?
Key investors in Iridia, Inc. include LifeSci Venture Partners, NIH RADx, Tech Coast Angels, Prime Movers Lab, TCA Venture Group.
Will Iridia, Inc. IPO soon?
No public IPO plans have been announced for Iridia, Inc..
How can I track Iridia, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Iridia, Inc.'s shares on secondary markets.